Binfeng Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Binfeng Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Fei Xiong
Hubei Cancer Hospital, Wuhan, China
1 shared publication- Nan He
Shaanxi University of Chinese Medicine 712046 Xianyang Shaanxi China
1 shared publication Qingquan Liu
Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication- Sheng Wang
Hubei Cancer Hospital, Wuhan, China
1 shared publication - Shengzhong Yi
Hubei Cancer Hospital, Wuhan, China
1 shared publication Xia Qiang
Shaanxi University of Chinese Medicine 712046 Xianyang Shaanxi China
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by Clausius Scientific Press, Inc. in MEDS Chinese Medicine
- Vol. 5 (10) , 32-39
The current situation and thinking of acupuncture and moxibustion in the prevention and treatment of premature ovarian insufficiency
With the adjustment of my country's fertility policy, improving the low fertility level and improving the fertility of women of childbearing age have become the focus of current clinical research, and premature ovarian insufficiency is the main cause of infertility in women of childbearing age. In recent years, researchers have made some progress in the clinical efficacy and mechanism research of acupuncture and moxibustion in the prevention and treatment of premature ovarian insufficiency. At the same time, the article combs and thinks about the problems and problems existing in the research on the prevention and treatment of premature ovarian insufficiency with acupuncture and moxibustion.
- 1 January 2023
- Published by Clausius Scientific Press, Inc. in MEDS Chinese Medicine
- Vol. 5 (10) , 32-39
Open AccessThe current situation and thinking of acupuncture and moxibustion in the prevention and treatment of premature ovarian insufficiency
With the adjustment of my country's fertility policy, improving the low fertility level and improving the fertility of women of childbearing age have become the focus of current clinical research, and premature ovarian insufficiency is the main cause of infertility in women of childbearing age. In recent years, researchers have made some progress in the clinical efficacy and mechanism research of acupuncture and moxibustion in the prevention and treatment of premature ovarian insufficiency. At the same time, the article combs and thinks about the problems and problems existing in the research on the prevention and treatment of premature ovarian insufficiency with acupuncture and moxibustion.
- Open Access
- 13 January 2022
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 21
Prognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis
Background: Esophageal cancer is one of the most common cancers with significant morbidity and mortality. It is important to predict the prognosis of patients. The purpose of this study was to comprehensively assess the prognostic and clinicopathologic significance of NLR in patients with esophageal cancer. Methods: A systematic literature search was performed using PubMed, Cochrane Library, Embase, Web of Science, MEDLINE, and CNKI. This meta-analysis was conducted in accordance with PRISMA guidelines. Hazard ratio (HR) with 95% confidence interval (CI) was used as the effect estimation to evaluate the prognostic role of NLR. Odds ratio (OR) was used to evaluate the relation between NLR and clinicopathologic characteristics. Results: A total of 8431 patients from 32 studies were included in this meta-analysis. The pooled results showed that elevated NLR might predict poor prognosis: The factors considered included overall survival (OS) (HR, 1.57; 95% CI, 1.40-1.75; P < .001), cancer-specific survival (CSS) (HR, 1.28; 95% CI, 1.09-1.49; P < .001), progression-free survival (PFS) (HR, 1.45; 95% CI, 1.29-1.72; P < .001), and disease-free survival (DFS) (HR,1.58; 95% CI, 1.27-1.97; P < .001). High NLR was also associated with tumor differentiation, tumor length, tumor invasion depth, lymph node metastasis, and clinical stage. No significant association was observed between NLR and metastasis stage (OR, 1.69; 95% CI, 0.98-2.98; P = .058). Conclusions: The results of this meta-analysis suggest that elevated NLR value might predict poor prognosis (OS, CSS, PFS, and DFS), according to abnormal clinicopathologic parameters.
- 13 January 2022
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 21
Open AccessPrognostic and Clinicopathologic Significance of Neutrophil-to-Lymphocyte Ratio in Esophageal Cancer: An Update Meta-Analysis
Background: Esophageal cancer is one of the most common cancers with significant morbidity and mortality. It is important to predict the prognosis of patients. The purpose of this study was to comprehensively assess the prognostic and clinicopathologic significance of NLR in patients with esophageal cancer. Methods: A systematic literature search was performed using PubMed, Cochrane Library, Embase, Web of Science, MEDLINE, and CNKI. This meta-analysis was conducted in accordance with PRISMA guidelines. Hazard ratio (HR) with 95% confidence interval (CI) was used as the effect estimation to evaluate the prognostic role of NLR. Odds ratio (OR) was used to evaluate the relation between NLR and clinicopathologic characteristics. Results: A total of 8431 patients from 32 studies were included in this meta-analysis. The pooled results showed that elevated NLR might predict poor prognosis: The factors considered included overall survival (OS) (HR, 1.57; 95% CI, 1.40-1.75; P < .001), cancer-specific survival (CSS) (HR, 1.28; 95% CI, 1.09-1.49; P < .001), progression-free survival (PFS) (HR, 1.45; 95% CI, 1.29-1.72; P < .001), and disease-free survival (DFS) (HR,1.58; 95% CI, 1.27-1.97; P < .001). High NLR was also associated with tumor differentiation, tumor length, tumor invasion depth, lymph node metastasis, and clinical stage. No significant association was observed between NLR and metastasis stage (OR, 1.69; 95% CI, 0.98-2.98; P = .058). Conclusions: The results of this meta-analysis suggest that elevated NLR value might predict poor prognosis (OS, CSS, PFS, and DFS), according to abnormal clinicopathologic parameters.